Titan Bio-Tech Ltd. logo

Titan Bio-Tech Ltd. (TITANBIO)

Market Closed
10 Aug, 22:00
MSE MSE
398. 40
-8.65
-2.125%
17.18B Market Cap
17.48 P/E Ratio
8% Div Yield
22,719 Volume
0 Eps
407.05
Previous Close
Add Transaction
Day Range
395 407
Year Range
86.6 555.65
Want to track TITANBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TITANBIO closed today lower at ₹398.4, a decrease of -2.125% from yesterday's close, completing a monthly increase of 0.8863% or ₹3.5. Over the past 12 months, TITANBIO stock lost -62.7315%.
TITANBIO pays dividends to its shareholders, with the most recent payment made on Oct 26, 2025. The next estimated payment will be in In 2 months on Oct 26, 2026 for a total of ₹2.
The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 6.5723%, based on the last three reports.
Titan Bio-Tech Ltd. has completed 1 stock splits, with the recent split occurring on Feb 20, 2026.
The company's stock is traded on one exchange.

TITANBIO Chart

People also search for

Kennametal India Ltd.
3,252.05
-2.5749%
Kovai Medical Center and Hospital Ltd.
6,105.9
+0.924%
Technocraft Industries (India) Limited
2,655
-1.5664%
Supriya Lifescience Ltd.
914.35
-0.6789%
Medi Assist Healthcare Services Ltd.
352
-0.1985%

Titan Bio-Tech Ltd. (TITANBIO) FAQ

What is the stock price today?

The current price is ₹398.40.

On which exchange is it traded?

Titan Bio-Tech Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is TITANBIO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 8%.

What is its market cap?

As of today, the market cap is 17.18B.

Has Titan Bio-Tech Ltd. ever had a stock split?

Titan Bio-Tech Ltd. had 1 splits and the recent split was on Feb 20, 2026.

Titan Bio-Tech Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
MSE Exchange
INE150C01011 ISIN
India Country
467 Employees
19 Sep 2025 Last Dividend
20 Feb 2026 Last Split
- IPO Date
Titan Bio-Tech Ltd. operates as a notable entity in the biotechnology sector, primarily focusing on producing and marketing a diverse range of biological products. The company's portfolio includes enzymes, provitamins, and protein supplements, serving various industries such as pharmaceuticals, agriculture, and food processing. Titan Bio-Tech's commitment to quality and innovation ensures that its products align with industry standards and regulatory requirements, facilitating their wide acceptance and integration across targeted sectors. By leveraging cutting-edge biotechnological processes, Titan Bio-Tech enhances product efficiency and quality, catering to a broad customer base that includes healthcare facilities, educational institutions, and research organizations. As a key player in the biotechnology marketplace, Titan Bio-Tech contributes significantly to advancements in scientific research and industrial applications, playing a vital role in supporting the development of sustainable biological solutions that meet industry demands.

Contact Information

Address: 903-909, Bigjos Tower
Phone: 91 11 2735 5742